Xiang-Qi-Tang increases avian pathogenic Escherichia coli-induced survival rate and regulates serum levels of tumor necrosis factor alpha, interleukin-1 and soluble endothelial protein C receptor in chicken

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 3, 2011, Pages 379-382

  He, Chang Liang ^a   Fu, Ben Dong ^a   Shen, Hai Qing ^a   Jiang, Xiao Lin ^b   Zhang, Chang Shuai ^a   Wu, Shuai Cheng ^a   Zhu, Wei ^c   Wei, Xu Bin ^a  

^a JILIN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF AGRICULTURE   (China)

^c GUIZHOU UNIVERSITY   (China)

Author keywords

Avian pathogenic Escherichia coli; Chicken; Inflammation; Thrombosis; Xiang Qi Tang

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR; INTERLEUKIN 1; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XIANG QI TANG;

ANDROGRAPHIS PANICULATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; AVIAN COLIBACILLOSIS; AVIAN PATHOGENIC ESCHERICHIA COLI; BLOOD LEVEL; CHICKEN; CONTROLLED STUDY; CYPERUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENDOTHELIAL PROTEIN C RECEPTOR BLOOD LEVEL; INTERLEUKIN 1 BLOOD LEVEL; LOW DRUG DOSE; NONHUMAN; SURVIVAL RATE; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD COAGULATION FACTORS; CHICKENS; DRUGS, CHINESE HERBAL; ESCHERICHIA COLI INFECTIONS; FIBRINOLYTIC AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; PHYTOTHERAPY; PLANTS, MEDICINAL; POULTRY DISEASES; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952355520     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.379     Document Type: Article

References (40)

1. Gibbs P. S., Petermann S. R., Wooley R. E., Avian Dis., 48, 751-758 (2004).
2. Dho-Moulin M., Fairbrother J. M., Vet. Res., 30, 299-316 (1999).
3. Seam N., Suffredini A. F., Drug Discov. Today Dis. Mech., 4, 83-93 (2007).
4. Aird W. C., Blood, 101, 3765-3777 (2003).
5. Esmon C. T., Br. J. Haematol., 131, 417-430 (2005).
6. Nelson S., Summer W. R., Infect. Dis. Clin. North Am., 12, 555-567 (1998).
7. Girardin E., Dayer J. M., Schweiz. Med. Wochenschr., 123, 480-491 (1993).
8. Libby P., Simon D. I., Circulation, 103, 1718-1720 (2001).
9. Carvalho A. C., Freeman N. J., J. Crit. Illness, 9, 51-75 (1994).
10. Cao C. Z., Gao Y. M., Li Y., Antalis T. M., Castellino F. J., Zhang L., J. Clin. Invest., 120, 1971-1980 (2010).
11. Esmon C. T., Ann. Med., 34, 598-605 (2002).
12. Fischer D., Nold M. F., Nold-Petry C. A., Furlan A., Veldman A., Vasc. Health Risk Manag., 5, 775-781 (2009).
13. Bae H., Park N., Kim Y., Hong M., Shin M., Kim S.H., Kim J., Cytokine, 51, 259-265 (2010).
14. Mishra U. S., Mishra A., Kumari R., Murthy P. N., Naik B. S., Indian J. Pharm. Sci., 71, 436-438 (2009).
15. Kligler B., Ulbricht C., Basch E., Kirkwood C. D., Abrams T. R., Miranda M., Singh Khalsa K. P., Giles M., Boon H., Woods J., Explore (New York), 2, 25-29 (2006).
16. Li H. B., Ge Y. K., Zhang L., Zheng X. X., Life Sci., 79, 1186-1193 (2006).
17. Cui R., He J., Wang B., Zhang F., Chen G., Yin S., Shen H., Cancer Chemoth. Pharm., 51, 75-80 (2003).
18. Minsook R., Eun H. K., Mison C., J. Ethnopharmacol., 115, 184-193 (2008).
19. Antão E. M., Glodde S., Li G., Sharifi R., Homeier T., Laturnus C., Diehl I., Bethe A., Philipp H. C., Preisinger R., Wieler L. H., Ewers C., Microb. Pathogenesis, 45, 361-369 (2008).
20. Huang H. J., Matsumoto M., Avian Dis., 43, 469-475 (1999).
21. Wooley R. E., Gibbs P. S., Brown T. P., Maurer J. J., Avian Dis., 44, 318-324 (2000).
22. Dinarello C. A., Int. J. Tissue React., 4, 65-75 (1992).
23. Moldawer L. L., Blood Purificat., 11, 128-133 (1993).
24. Murch S. H., Nutrition, 14, 780-783 (1998).
25. Diel R., Hauer B., Loddenkemper R., Manger B., Krüger K., Z. Rheumatol., 68, 411-416 (2009).
26. Lynn W. A., Cohen J., Clin. Infect. Dis., 20, 143-158 (1995).
27. Ozmen L., Pericin M., Hakimi J., Chizzonite R. A., Wysocka M., Trinchieri G., J. Exp. Med., 180, 907-915 (1994).
28. Chao W. W., Kuo Y. H., Hsieh S. L. Lin B. F., Evid-based Compl. Alt., 9, 1-9 (2009).
29. Chandrasekaran C. V., Gupta A., Agarwal A., J. Ethnopharmacol., 129, 203-207 (2010).
30. Yuan Y., Sun M., Li K. S., World J. Gastroenterol., 15, 3676-3680 (2009).
31. Fisher C. J. Jr., Yan S. B., Crit. Care Med., 28, S49-S56 (2000).
32. Mesters R. M., Helterbrand J., Utterback B. G., Yan B., Chao Y. B., Fernandez J. A., Griffin J. H., Hartman D. L., Crit. Care Med., 28, 2209-2216 (2000).
33. Esmon C. T., Chest, 124, 26S-32S (2003).
34. Regan L. M., Stearns-Kurosawa D. J., Kurosawa S., Mollica J., Fukudome K., Esmon C. T., J. Biol. Chem., 271, 17499-17503 (1996).
35. Gu J. M., Katsuura Y., Ferrell G. L., Grammas P., Esmon C. T., Blood, 95, 1687-1693 (2000).
36. Sheeja K., Shihab P. K., Kuttan G., Immunopharm. Immunother., 28, 129-140 (2006).
37. Parichatikanond W., Suthisisang C., Dhepakson P., Herunsalee A., Int. Immunopharmacol., 10, 1361-1373 (2010).
38. Liu J., Wang Z. T., Ge B. X., Int. Immunopharmacol., 8, 951-958 (2008).
39. Gao X. H., Xu X. X., Pan R., Li Y., Luo Y. B., Xia Y. F., Murata K., Matsuda H., Dai Y., J. Nat. Med., 63, 421-429 (2009).
40. Gao X. H., Xu X. X., Pan R., Wang C., Sheng R., Xia Y. F., Dai Y., Inflammation, in press (2010).